Journal List > Diabetes Metab J > v.45(4) > 1147888

This corrects the article "Hyperinsulinemia in Obesity, Inflammation, and Cancer" on page 285.
TOOLS
Zhang, Wellberg, Kopp, and Johnson: Hyperinsulinemia in Obesity, Inflammation, and Cancer
Erratum

Diabetes Metab J 2021;45(4):622-622.

Published online: 30 July 2021

DOI: https://doi.org/10.4093/dmj.2021.0131

Hyperinsulinemia in Obesity, Inflammation, and Cancer

Anni M.Y. Zhang1, Elizabeth A. Wellberg2, Janel L. Kopp1, James D. Johnson1

1Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada

2Department of Pathology, University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Harold Hamm Diabetes Center, Oklahoma City, OK, USA

Copyright © 2021 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Diabetes Metab J 2021;45:285-311. https://doi.org/10.4093/dmj.2020.0250
In the article cited above, there was a spelling error in the Fig. 1. In the middle of Fig. 1, “obsity” was misspelled. The correct word is “obesity.”
We apologize for any inconvenience that this may have caused.

Fig. 1.
Trade-offs with insufficient and excessive circulating insulin levels.
dmj-2021-0131f1.tif
TOOLS
Similar articles